| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cardiff Oncology, Inc. (CRDF) has 6 insiders with recent SEC Form 4 filings, including 10 buys and 1 sell. CRDF is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 263.4K | $342.5K | - | |
| Dir | 228.1K | $296.5K | - | |
| Dir | 228.1K | $296.5K | - | |
| Dir | 209.3K | $272.1K | - | |
| Dir | 199.2K | $259.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 14, 2020 | Brancaccio John P | Director | Buy | 6,993 | $1.43 | $9,999.99 | +308.5% | |
| May 14, 2020 | Markin Rodney S | Director | Buy | 20,979 | $1.43 | $29,999.97 | +292.1% | |
| May 11, 2020 | Pace Gary W66 | Director | Buy | 447,761 | $1.34 | $599,999.74 | New | |
| Jun 20, 2018 | Markin Rodney S | Director | Buy | 41,200 | $0.85 | $35,020.00 | +182.2% | |
| Jun 8, 2018 | Tennant Stanley | Director | Buy | 10,000 | $0.80 | $8,000.00 | +4.4% | |
| Jun 8, 2018 | Brancaccio John P | Director | Buy | 10,000 | $0.80 | $8,000.00 | +23.2% | |
| Sep 5, 2017 | Tennant Stanley | Director | Sell | 8,334 | $0.69 | $5,750.46 | -3.8% | |
| Dec 19, 2016 | Tennant Stanley | Director | Buy | 10,000 | $2.10 | $21,000.00 | +4.8% | |
| Dec 16, 2016 | Welch William J | CEO | Buy | 4,750 | $2.09 | $9,943.50 | +190.0% | |
| Dec 16, 2016 | Tennant Stanley | Director | Buy | 14,966 | $2.00 | $29,932.00 | +7.8% |